spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  obstructive sleep apnea 

 HSMN NewsFeed - 5 Sep 2024
Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations
Devices Orthopaedic Personnel
 HSMN NewsFeed - 24 Jan 2024
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 5 May 2022
XII Medical Completes $30 Million Series A Financing
Devices Venture Capital
 HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 27 Jan 2022
SciSparc Presents New Leadership Lineup
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 24 Nov 2020
Signifier Medical Technologies appoints Alastair Maxwell as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 28 Oct 2020
Citrine Medicine Advances Efforts to Create the Very First Rare Disease Ecosystem in China Through Strategic Partnership with Bioprojet to License Exclusive Rights for the Use of Orphan Narcolepsy Therapy Wakix(R) (pitolisant)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Oct 2020
Signifier Medical Technologies appoints Travis Nieman as Managing Director International
Devices Personnel
 HSMN NewsFeed - 16 Sep 2020
Signifier Medical Technologies Closes $10M Series C Funding Round
Devices Venture Capital
 HSMN NewsFeed - 15 Nov 2019
Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Dec 2018
Therapix Biosciences Terminates FSD Acquisition Letter of Intent
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Nov 2018
Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Jun 2018
FDA Authorizes FRESCA Medical To Market New Positive Airway Pressure Delivery System To Treat Sleep Apnea
Devices FDA
 HSMN NewsFeed - 20 Mar 2018
Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Mar 2018
Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Dec 2017
Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Nov 2017
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Jul 2017
EnteroMedics Announces First Veterans Choice Program vBloc(R) Implant for Obesity at Methodist Dallas Medical Center
Devices
 HSMN NewsFeed - 21 Jun 2017
EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference
Devices
 HSMN NewsFeed - 31 May 2017
EnteroMedics Announces First vBloc(R) Neurometabolic Therapy Implant at AMITA Health Adventist Medical Center Bolingbrook
Devices Neurology
 HSMN NewsFeed - 18 May 2017
EnteroMedics Announces First vBloc(R) Neurometabolic Therapy Implant at McGuire Veterans Affairs Medical Center
Devices Neurology
 HSMN NewsFeed - 11 Apr 2017
Philips Simplifies Travel for Sleep Apnea Patients with New Compact and Connected Dreamstation Go Sleep Therapy Device
Devices Product Launch
 HSMN NewsFeed - 12 Jan 2017
ResMed's myAir(TM) Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea
Devices
 HSMN NewsFeed - 13 Sep 2016
vBloc Institute Demonstrates Positive Clinical Success in Patients Struggling with Weight Loss as Compared to Pivotal FDA Trial with EnteroMedics vBloc(R) Therapy in Combination with vBloc(R) Achieve Program
Devices Neurology
 HSMN NewsFeed - 5 Jul 2016
NightBalance Closes EUR 12.5 Million Series B Financing to Support Commercial Rollout in Europe and Enter the U.S. Market with Its Innovative Sleep Apnea Device
Devices Venture Capital Personnel
 HSMN NewsFeed - 29 Jun 2016
EnteroMedics Highlights Recent Patient Success with vBloc(R) Therapy in Combination with vBloc(R) Achieve Program
Devices
 HSMN NewsFeed - 9 Feb 2016
LifeWatch(TM) Receives FDA Clearance for Its Continuous Vital Signs Monitoring Service
Devices Monitoring FDA
 HSMN NewsFeed - 18 Jan 2016
LifeWatch Receives FDA Clearance for its Mobile Cardiac Telemetry 1-Lead Patch
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 10 Nov 2014
ImThera Medical, Inc. Receives FDA Approval for Pivotal Study for Obstructive Sleep Apnea Device
Devices FDA
 HSMN NewsFeed - 5 Jun 2014
Dehaier Receives CFDA Approval for Morpheus Ox Sleep Diagnostic Software
Devices Regulatory
 HSMN NewsFeed - 1 May 2014
FDA Approves Inspire(R) Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea
Devices FDA
 HSMN NewsFeed - 19 Feb 2014
Apex Embarks on Counter Actions Against ResMed in Europe
Devices Litigation
 HSMN NewsFeed - 13 Jan 2014
Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 11 Oct 2013
Covidien Launches New Capnography Monitoring Solution
Devices Monitoring Product Launch
 HSMN NewsFeed - 2 Oct 2013
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
Devices Otolaryngology
 HSMN NewsFeed - 18 Jun 2013
Sorin Group Launches REPLY(TM) 200 Family of Pacemakers with Sleep Apnea Monitoring for Better Management of Cardiovascular Co-Morbidities1
Devices Cardiology Product Launch
 HSMN NewsFeed - 30 May 2013
Breathe Technologies Sleep System Receives FDA Clearance
Devices FDA
 HSMN NewsFeed - 20 May 2013
Itamar-Medical Appoints Gilad Glick as CEO; Transitioning from Current Role as Vice President Worldwide Sales and Marketing of Johnson & Johnson’s Cardio Division
Devices Personnel
 HSMN NewsFeed - 10 Dec 2012
ApniCure Appoints David P. White, M.D., as Chief Scientific Officer
Devices Personnel
 HSMN NewsFeed - 21 Sep 2012
VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 May 2012
ApniCure Receives FDA 510(k) Clearance to Market Winx(TM) Sleep Therapy System for Treatment of Obstructive Sleep Apnea
Devices FDA
 HSMN NewsFeed - 23 Apr 2012
SeptRx(R) completes enrollment for its “InterSEPT” CE mark trial, partners with CoRRect Medical GmbH for European distribution of its SeptRx Intrapocket PFO Occluder (IPO)
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 20 Apr 2012
VIVUS Appoints Ernest Mario, Ph.D. to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2012
Par Pharmaceutical Begins Shipment of Generic Provigil(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 27 Mar 2012
VIVUS Announced Expansion of Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2012
SeptRx(R) reports first 20 patients have been enrolled in its “InterSEPT” CE Mark trial of the SeptRx(R) Intrapocket PFO Occluder (IPO)
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 23 Dec 2011
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
Biopharmaceuticals
 HSMN NewsFeed - 3 Nov 2011
Ventus Medical Appoints Two Senior Executives
Devices Personnel
 HSMN NewsFeed - 3 Oct 2011
Ventus Medical Launches Provent(R) Sleep Apnea Therapy in Australia and New Zealand
Devices
 HSMN NewsFeed - 16 Sep 2011
Natus Acquires Embla Systems LLC - Leading Sleep Diagnostic Company
Devices Mergers & Acquisitions
 HSMN NewsFeed - 5 Aug 2011
Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 25 May 2011
VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
Biopharmaceuticals Urology Oncology
 HSMN NewsFeed - 21 Jan 2011
VIVUS Provides Regulatory Update on QNEXA NDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Dec 2010
Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Dec 2010
VIVUS Files European Marketing Authorization Application for QNEXA(R) in the Treatment of Obesity
Biopharmaceuticals
 HSMN NewsFeed - 17 Dec 2010
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Nov 2010
Inspire Medical Systems Announces FDA approval for Pivotal Clinical Trial
Devices Neurology FDA
 HSMN NewsFeed - 2 Jun 2010
Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer
Devices Neurology Personnel
 HSMN NewsFeed - 3 May 2010
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2010
Outcomes of Patients Dismissed from the Hospital with Noncardiac Chest Pain
Cardiology
 HSMN NewsFeed - 26 Mar 2010
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa(R) for the Treatment of Obesity
Biopharmaceuticals
 HSMN NewsFeed - 15 Mar 2010
Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care
Devices Cardiology Monitoring
 HSMN NewsFeed - 11 Jan 2010
Mylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil(R)
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 16 Dec 2009
Ethicon Announces Definitive Agreement to Acquire Acclarent
Devices Mergers & Acquisitions
 HSMN NewsFeed - 3 Dec 2009
Apnex Medical, Inc. Raises Additional $14 Million
Devices Venture Capital
 HSMN NewsFeed - 3 Dec 2009
Nasal-Aire(R) II Petite Receives FDA 510(k) Clearance for Pediatric Use
Devices FDA
 HSMN NewsFeed - 5 Oct 2009
PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market
Devices Surgery Distribution
 HSMN NewsFeed - 24 Sep 2009
Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Sep 2009
ImThera Medical Completes Development of Targeted Hypoglossal Neurostimulation Treatment for OSA
Devices
 HSMN NewsFeed - 9 Jun 2009
Masimo Debuts New Rad-8(R) Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009
Devices Monitoring
 HSMN NewsFeed - 8 Jun 2009
Inspire Medical Systems Completes $17 Million Series B Financing
Devices Venture Capital
 HSMN NewsFeed - 1 Jun 2009
Cephalon Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder and Narcolepsy
Biopharmaceuticals
 HSMN NewsFeed - 9 Apr 2009
Ventus Medical Appoints John McCutcheon as President and CEO
Devices Personnel
 HSMN NewsFeed - 17 Mar 2009
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2009
Inspire Medical Systems Completes First Implant of the Inspire II System to Treat Obstructive Sleep Apnea
Devices
 HSMN NewsFeed - 30 Oct 2008
GE Healthcare Completes Acquisition of Vital Signs, Inc., Expanding GE's Monitoring, Anesthesia and Respiratory Care Offerings
Devices Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 24 Jul 2008
GE Healthcare to Acquire Vital Signs, Inc., Expanding GE's Monitoring, Anesthesia and Respiratory Care Offerings
Devices Mergers & Acquisitions
 HSMN NewsFeed - 5 Jun 2008
Covidien Launches Sandman Info(TM) and Sandman Auto(TM) CPAP Devices in the United States
Devices
 HSMN NewsFeed - 11 Feb 2008
Covidien Introduces Sandman Intro(TM) CPAP Device
Devices
 HSMN NewsFeed - 21 Dec 2007
Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
Devices Mergers & Acquisitions
 HSMN NewsFeed - 4 Oct 2007
Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
Devices Monitoring
 HSMN NewsFeed - 2 Oct 2007
Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
Devices Mergers & Acquisitions
 HSMN NewsFeed - 18 Sep 2007
New U.S. Multi-Center Clinical Study Affirms Efficacy and Benefit of Restore Medical's Pillar(R) Procedure
Devices
 HSMN NewsFeed - 22 Aug 2007
Bariatric Surgical Society Takes on New Name, New Mission and New Surgery
Surgery Endocrinology
 HSMN NewsFeed - 18 Jun 2007
Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jun 2007
XLTEK Announces New Senior Management Appointment
Devices Personnel
 HSMN NewsFeed - 30 May 2007
Teleflex Medical Launches Bravo Nasal Pillow CPAP Mask
Devices
 HSMN NewsFeed - 22 May 2007
Aspire Medical Announces First Implant in US and Start of Clinical Trial to Treat Sleep Apnea
Devices
 HSMN NewsFeed - 14 May 2007
APNEX Medical, Inc. Raises $16.1 Million in Series 'A' Financing
Devices Venture Capital
 HSMN NewsFeed - 1 May 2007
Aspire Medical Appoints Roseanne Varner as President and CEO
Devices Personnel
 HSMN NewsFeed - 23 Apr 2007
ResMed Issues a Voluntary Recall for Certain S8 Flow Generators
Devices Product Recall
 HSMN NewsFeed - 30 Mar 2007
Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Mar 2007
Respironics Receives 510(k) Clearance from FDA for BiPAP(R) autoSV(TM) Device Designed for Complicated Sleep-Disordered Breathing Patients
Devices FDA
 HSMN NewsFeed - 6 Mar 2007
New Hybrid(TM) CPAP Mask Emerging as a Strong Alternative to C-Flex/EPR and Bi-level Machines
Devices
 HSMN NewsFeed - 19 Dec 2006
Wisconsin Physician Services Now Covers Restore Medical's Pillar(R) Palatal Implant System for Obstructive Sleep Apnea
Devices Reimbursement
 HSMN NewsFeed - 7 Dec 2006
Cephalon Provides Update Related to Final NUVIGIL(TM) Labeling
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Nov 2006
VIASYS Healthcare Inc. Acquires Assets of Hoffman Laboratories, LLC Acquisition Adds to VIASYS' Presence in Sleep Therapy
Devices Mergers & Acquisitions
 HSMN NewsFeed - 5 Oct 2006
Six New Studies Document Efficacy and Sustained Benefit of Restore Medical's Pillar(R) Procedure
Devices
 HSMN NewsFeed - 29 Sep 2006
Restore Medical Names Vice President of Sales
Devices Personnel
 HSMN NewsFeed - 21 Sep 2006
Vital Signs, Inc. Announces FDA Clearance to Market Sleep and Ventilation Products
Devices FDA
 HSMN NewsFeed - 6 Sep 2006
Health Canada Approves Restore Medical's Pillar(R) Palatal Implant System
Devices Regulatory
 HSMN NewsFeed - 12 Jul 2006
VIASYS Healthcare Inc. Acquires Tiara Medical Systems, Inc.
Devices Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 50

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 50 additional stories matching:
obstructive sleep apnea
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.